Matches in Wikidata for { <http://www.wikidata.org/entity/Q65362229> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q65362229 description "clinical trial" @default.
- Q65362229 description "ensayu clínicu" @default.
- Q65362229 description "klinisch onderzoek" @default.
- Q65362229 description "клінічне випробування" @default.
- Q65362229 name "To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women" @default.
- Q65362229 name "To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women" @default.
- Q65362229 type Item @default.
- Q65362229 label "To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women" @default.
- Q65362229 label "To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women" @default.
- Q65362229 prefLabel "To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women" @default.
- Q65362229 prefLabel "To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women" @default.
- Q65362229 P1050 Q65362229-11C4E819-EFA9-4872-97C2-0042EE148AA4 @default.
- Q65362229 P1132 Q65362229-BA16B3CD-3671-4AED-BCD6-5CC8FC6EFCCB @default.
- Q65362229 P1476 Q65362229-D4C6A1BE-DDB1-4A2B-B623-2870C8A0284C @default.
- Q65362229 P2899 Q65362229-08C7BBF2-6D50-48B8-89F2-AD4D2B916BE8 @default.
- Q65362229 P3098 Q65362229-EC3C5D7F-12EF-4327-9DAF-CF32241B30BB @default.
- Q65362229 P31 Q65362229-C6AEF743-C9F4-4575-B9E8-9614CD8FF0C2 @default.
- Q65362229 P4844 Q65362229-19D90191-0795-4C9B-B3D0-9873F71BDB1A @default.
- Q65362229 P4844 Q65362229-56F137BB-61AB-402B-A68A-3FB9633BC25B @default.
- Q65362229 P580 Q65362229-FFC7B58E-5E8C-486E-AEB7-0DB20E9B5918 @default.
- Q65362229 P582 Q65362229-69F42B85-E61D-44ED-A9A0-1A6B42C848D6 @default.
- Q65362229 P6099 Q65362229-60511BC8-E541-4640-9CE4-C277C03B8E70 @default.
- Q65362229 P6153 Q65362229-F71B05D6-9359-4AA3-A82B-6A54623D583D @default.
- Q65362229 P8363 Q65362229-BBA06D28-1C20-4821-ACDF-71032956EA63 @default.
- Q65362229 P1050 Q165328 @default.
- Q65362229 P1132 "+196" @default.
- Q65362229 P1476 "For 12months, the Multi Center, Randomized, Open-label Comparative Clinical Study to Evaluate the Efficacy and the Safety of Monthly(RisenexM Group) Versus Weekly Oral Risedronate(Risenexsplus Group) With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women(Phase IV)" @default.
- Q65362229 P2899 "+19" @default.
- Q65362229 P3098 "NCT01904110" @default.
- Q65362229 P31 Q30612 @default.
- Q65362229 P4844 Q27161510 @default.
- Q65362229 P4844 Q408724 @default.
- Q65362229 P580 "2012-12-01T00:00:00Z" @default.
- Q65362229 P582 "2014-05-29T00:00:00Z" @default.
- Q65362229 P6099 Q42825046 @default.
- Q65362229 P6153 Q624119 @default.
- Q65362229 P8363 Q78089383 @default.